Secnidazole

DRUG2 trials

Sponsors

Lupin Research Inc

Conditions

Bacterial VaginosesTrichomonas Infection

Phase 3

A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis

CompletedNCT03935217

Lupin Research IncTrichomonas Infection

Start: 2019-04-23End: 2020-03-25Updated: 2023-10-04

Phase 4

Evaluate the Safety of a Single Oral Dose of Solosec™ (Secnidazole) 2g for the Treatment of Adolescent Girls With BV

CompletedNCT03937869

Lupin Research IncBacterial Vaginoses

Start: 2018-11-28End: 2020-11-05Updated: 2020-12-19

Related Papers

Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data

BMJ Open2023-08-011 citations

Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study

Clinical Infectious Diseases2021-03-1650 citations